Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference
Theratechnologies (NASDAQ: THTX) announced that Paul Levesque, President and CEO, will present at the Bloom Burton & Co. Healthcare Investor Conference on April 21, 2021, at 10:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies (NASDAQ: THTX) announced that Paul Levesque, President and CEO, will present at the Bloom Burton & Co. Healthcare Investor Conference on April 21, 2021, at 10:30 a.m. ET. The event will be accessible via a live webcast, with the link provided for attendees. This conference highlights the company’s focus on developing innovative therapies to meet unmet medical needs.
For more information about Theratechnologies, interested parties can visit their website.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was -3.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will present at the Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 21, 2021 at 10:30 a.m. ET.
The live webcast will be available at https://wsw.com/webcast/bloomburton6/thtx/. The live and archived webcast link will also be available in the ‘News’ section of the Company’s website.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
ir@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.